Densitometric measurement of increased endothelial permeability in arteriosclerotic plaques and inhibition of permeability under the influence of two calcium antagonists

      This paper is only available as a PDF. To read, Please Download here.


      A densitometric technique was established to investigate quantitative changes in endothelial permeability for horseradish peroxidase (HRP), mol. wt. 40000 daltons, in rabbit carotid artery. Repeated weak electrical stimulations of rabbit carotid arterial walls with implanted electrodes lead to fibromuscular plaques mainly beneath the anode. It could be demonstrated that there exists a typical growth curve of the plaques dependent on the number of days of electrostimulation, with a fast proliferation rate of smooth muscle cells in the first 2 weeks of electrostimulation, and an increasing retardation of proliferation during the next 4 weeks. Endothelial permeability for HRP increases in close relation to the plaque development. Intravenous applications of single doses of the calcium entry blockers flunarizine or nimodipine are able to inhibit the increased permeability of the endothelial lining covering arteriosclerotic plaques. The intensity of the inhibitory action of these calcium antagonists correlates with the size of the arteriosclerotic plaques in inverse proportion, but nevertheless in large plaques an inhibitory effect is seen.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Kurozumi T.
        Electron microscopic study on the permeability of the aorta and basilar artery of the rabbit — with special reference to the changes of permeability by hypercholesterolemia.
        Exp. Mol. Pathol. 1975; 23: 1
        • Veress B.
        • Bálint A.
        • Kóczé A.
        • Nagy Z.
        • Jellinek H.
        Increasing aortic permeability by atherogenic diet.
        Atherosclerosis. 1970; 11: 369
        • Hüttner I.
        • More R.H.
        • Rona G.
        Fine structural evidence of specific mechanism for increased endothelial permeability in experimental hypertension.
        Am. J. Pathol. 1970; 61: 395
        • Shimamoto T.
        Contracting and swallowing activity of arterial endothelial cells induced by cholesterol, epinephrine, angiotensin II and bradykinin. An electron microscopic study.
        J. Jpn. Atheroscler. Soc. 1973; 1: 29
        • Kling D.
        • Holzschuh T.
        • Strohschneider T.
        • Betz E.
        Enhanced endothelial permeability and invasion of leucocytes into the artery wall as initial events in experimental arteriosclerosis.
        Intern. Angiol. 1987; 6: 21
        • Betz E.
        • Hämmerle H.
        • Strohschneider T.
        Inhibition of smooth muscle cell proliferation and endothelial permeability with flunarizine in vitro and in experimental atheromas.
        Res. Exp. Med. 1985; 185: 325
        • Betz E.
        • Schlote W.
        Responses of vessel walls to chronically applied electrical stimuli.
        Basic Res. Cardiol. 1979; 74: 10
        • Forssmann W.G.
        A method for in vivo diffusion tracer studies combining perfusion fixation with intravenous tracer injection.
        Histochemie. 1969; 20: 277
        • Haust M.D.
        Early permeability changes in human atherosclerotic lesions.
        Prog. Biochem. Pharmacol. 1977; 13: 203
        • Jellinek H.
        • Detre Z.
        Role of the altered transmural permeability in the pathomechanism of arteriosclerosis.
        Pathol. Res. Pract. 1986; 181: 693
        • Ross R.
        • Glomset J.A.
        The pathogenesis of atherosclerosis.
        New Engl. J. Med. 1976; 295: 420
        • Suzuki K.
        • Moris J.
        • Ooneda G.
        Increased permeability of the hypertensive rat arteries.
        J. Jpn. Atheroscler. Soc. 1980; 8: 109
        • Westergaard E.
        • Van Deurs B.
        • Bronsted H.E.
        Increased vesicular transfer of horseradish peroxidase across cerebral endothelium evoked by acute hypertension.
        Acta Neuropathol. 1977; 37: 141
        • Boutet M.
        • Bazin M.
        • Turcotte H.
        • Lagace R.
        Effect of cigarette smoke on rat thoracic aorta.
        Artery. 1980; 7: 56
        • Kerényi T.
        • Horváth G.
        • Detre Z.
        • Kurunczi S.
        • Jellinek H.
        Permeability of the post-ischemic rat aorta.
        Acta Morphol. Acad. Sci. Hung. 1975; 23: 83
        • Westergaard E.
        • Go G.
        • Klatzo I.
        • Spatz M.
        Increased permeability of cerebral vessels to horseradish peroxidase induced by ischemia in Mongolian gerbils.
        Acta Neuropathol. 1976; 35: 307
        • Robertson A.L.
        • Khairallah P.A.
        Arterial endothelial permeability and vascular disease. The “trap door” effect.
        Exp. Mol. Pathol. 1975; 18: 241
        • Shimamoto T.
        • Moriya K.
        • Kobayashi M.
        • Takahashi T.
        • Numano F.
        Contraction of endothelial cells as a key mechanism in atherogenesis and treatment of atherosclerosis with endothelial relaxants.
        Atherosclerosis. 1977; 28: 234
        • Yorro T.
        • Burnstock G.
        Filament bundles and contractility of endothelial cells in coronary arteries.
        Cell Tissue Res. 1973; 138: 85
        • Borgers M.
        • Ghoos-Thoné F.
        • Van Nueten J.M.
        Effects of flunarizine in the distribution of calcium in vascular smooth muscle.
        Blood Vessels. 1980; 17: 123
        • Van Nueten J.M.
        • Van Beck J.
        • Janssen P.A.J.
        The vascular effects of flunarizine as compared with those of other clinically used vasoactive substances.
        Drug Res. 1978; 28: 2082
        • Harper A.M.
        • Craigen L.
        • Kazada S.
        Effect of calcium antagonist nimodipine on cerebral blood flow and metabolism in the primate.
        J. Cerebr. Blood Flow Metab. 1981; 1: 349
        • Hladovec J.
        • De Clerk F.
        Protection by flunarizine against endothelial cell injury in vivo.
        Angiology. 1981; 32: 448